The effect of Alum vaginal solution in vaginal candidiasis

Phase 3

Recruiting

• Conditions: Vaginal Candidiasis.; Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere; N77.1

• Registration Number: IRCT20200916048736N1
• Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

Being between 18 and 45 years old
Willingness to participate in the study
Being married
Existence of clinical signs indicating candidiasis vaginitis
Positive wet smear for candida

Exclusion Criteria

Pregnancy
Breastfeeding
Abnormal uterine bleeding
Body mass index equal to or greater than 30
History of known chronic diseases: diabetes, weakened immune system, epilepsy, hypertension, etc.
History of recurrent candidiasis vulvovaginitis (4 or more than 4 times a year)
Existence of other vaginal infections with candidiasis
Taking oral contraceptive pills
Taking corticosteroids and antibiotics in the last 2 weeks
Taking systemic antifungal drugs in the last 4 weeks
Taking a cream, suppository or vaginal douche in the last 48 hours
History of allergy to clotrimazole

Study & Design

• Study Type: interventional
• Study Design: Not specified